Your browser is no longer supported. Please, upgrade your browser.
ZSAN Zosano Pharma Corporation weekly Stock Chart
ZSAN [NASD]
Zosano Pharma Corporation
Index- P/E- EPS (ttm)-9.39 Insider Own1.97% Shs Outstand12.00M Perf Week-3.46%
Market Cap43.56M Forward P/E- EPS next Y-2.12 Insider Trans0.00% Shs Float10.14M Perf Month-3.97%
Income-32.70M PEG- EPS next Q-0.69 Inst Own59.70% Short Float13.46% Perf Quarter-10.15%
Sales- P/S- EPS this Y61.20% Inst Trans-2.49% Short Ratio14.84 Perf Half Y-19.51%
Book/sh2.38 P/B1.53 EPS next Y- ROA-116.30% Target Price19.00 Perf Year-69.25%
Cash/sh2.46 P/C1.48 EPS next 5Y- ROE-185.20% 52W Range3.29 - 25.70 Perf YTD-65.10%
Dividend- P/FCF- EPS past 5Y-46.60% ROI- 52W High-85.88% Beta1.82
Dividend %- Quick Ratio5.40 Sales past 5Y- Gross Margin- 52W Low10.33% ATR0.21
Employees39 Current Ratio5.40 Sales Q/Q- Oper. Margin- RSI (14)43.17 Volatility4.38% 5.31%
OptionableNo Debt/Eq0.16 EPS Q/Q83.00% Profit Margin- Rel Volume0.82 Prev Close3.62
ShortableYes LT Debt/Eq0.12 EarningsNov 14 AMC Payout- Avg Volume91.93K Price3.63
Recom1.00 SMA20-3.40% SMA50-5.16% SMA200-29.24% Volume75,609 Change0.28%
Mar-24-17Initiated Piper Jaffray Overweight $4
Aug-11-16Downgrade Ladenburg Thalmann Buy → Neutral
Nov-11-15Reiterated ROTH Capital Buy $11 → $7
Sep-29-15Reiterated ROTH Capital Buy $20 → $11
Feb-23-15Initiated ROTH Capital Buy $20
Dec-12-18 08:30AM  Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta for M207 GlobeNewswire
Nov-14-18 04:05PM  Zosano Pharma Reports Third Quarter 2018 Financial Results and Operational Update GlobeNewswire
Nov-07-18 04:30PM  Zosano Pharma to Host Conference Call on Third Quarter 2018 Financial Results and Provide Operational Update GlobeNewswire +7.30%
Oct-25-18 09:15AM  Recent Analysis Shows Stellus Capital Investment, Nuance Communications, ProPetro Holding, Sanchez Energy, Granite Point Mortgage Trust, and Zosano Pharma Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-23-18 08:30AM  Zosano Treats over 4,000 Migraines and Reaches an Important Goal in M207-ADAM Long-term Safety Study GlobeNewswire
Oct-18-18 08:00AM  Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients Perspective GlobeNewswire
Oct-16-18 08:30AM  Zosano Appoints New Chief Financial Officer GlobeNewswire
Oct-03-18 08:30AM  Zosano Pharma Engages Contract Manufacturer as Part of the Commercialization Strategy for M207 GlobeNewswire
Sep-26-18 08:30AM  Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment GlobeNewswire
Sep-19-18 08:30AM  Zosano Pharma Completes Manufacture of M207 Registration Batches GlobeNewswire
Sep-14-18 09:56AM  Shareholders Should Check If Insiders Own Shares In Zosano Pharma Corporation (NASDAQ:ZSAN) Simply Wall St.
Sep-06-18 08:30AM  Zosano Pharma to Present Phase 3 Safety Study Update for ADAM Technology in the Delivery of Zolmitriptan at the 5th Annual Transdermal & Intradermal Drug Delivery Systems Conference GlobeNewswire
Sep-05-18 08:30AM  Zosano Pharma and Collaborators to Present Efficacy Data for M207 in the Treatment of Migraine at the 17th Biennial Migraine Trust International Symposium (MTIS) GlobeNewswire -5.48%
Aug-09-18 04:00PM  Zosano Pharma Reports Second Quarter 2018 Financial Results and Operational Update GlobeNewswire -5.05%
02:30PM  Zosano Pharma Corp. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:30AM  Zosano Pharma to Host Conference Call on Second Quarter 2018 Financial Results and Provide Operational Update GlobeNewswire
Jul-30-18 07:20AM  Breakfast Technical Briefing on ZIOPHARM Oncology and Three Other Additional Biotech Stocks ACCESSWIRE
Jul-17-18 08:30AM  Zosano Announces Positive Data from a Nonclinical Evaluation of Pharmacokinetics and Skin Tolerability Study for ADAM Technology for the Delivery of Zolmitriptan GlobeNewswire +13.04%
Jul-02-18 07:25AM  Initiating Free Research Reports on ZIOPHARM Oncology and Three Other Biotech Equities ACCESSWIRE
Jun-28-18 07:27AM  Zosano Pharma (ZSAN) Stock Can Reach $19 in the Next 12 Months, Says BTIG SmarterAnalyst
Jun-27-18 02:00PM  Zosano to Present Additional Analyses from the ZOTRIP Pivotal Study on Pain Relief and Recurrence at the 2018 American Headache Society (AHS) Meeting GlobeNewswire
Jun-20-18 08:30AM  Zosano Announces Publication on Adhesive Dermally-Applied Microarray (ADAM) Technology for the Delivery of Zolmitriptan in Migraine in Journal of Pharmaceutics GlobeNewswire
May-31-18 08:20AM  Market Trends Toward New Normal in ANSYS, Pearson, Qualys, H. B. Fuller, Cabot Microelectronics, and Zosano Pharma Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-30-18 07:25AM  Complimentary Technical Snapshots on VIVUS and Three More Biotech Stocks ACCESSWIRE
May-23-18 08:30AM  Zosano Announces Publication of Most Bothersome Symptom Data from the ZOTRIP Pivotal Study in Headache: The Journal of Head and Face Pain GlobeNewswire
May-22-18 08:30AM  Zosano Appoints Steven A. Elms to Board of Directors GlobeNewswire
May-15-18 04:00PM  Zosano Pharma Reports First Quarter 2018 Financial Results and Operational Update GlobeNewswire
May-14-18 08:30AM  Zosano Reaches Another Enrollment Milestone in M207-ADAM Long-term Safety Study GlobeNewswire +10.54%
May-08-18 04:05PM  Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update GlobeNewswire
Apr-05-18 08:15AM  Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Apr-03-18 04:05PM  Zosano Announces Closing of Public Offering of Common Stock GlobeNewswire
Apr-02-18 12:56PM  Zosano Pharma to Host Conference Call to Provide Operational Update GlobeNewswire
Mar-29-18 09:00AM  Zosano Announces Pricing of Public Offering of Common Stock GlobeNewswire -45.04%
08:17AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:37AM  Zosano Pharma's stock plummets after stock offering filed, assumed to price at deep discount MarketWatch
Mar-20-18 07:30AM  Wired News Zosano Reports Enrollment Milestone in its M207-ADAM Study ACCESSWIRE
Mar-16-18 11:02AM  Should You Buy Zosano Pharma Corporation (NASDAQ:ZSAN) Now? Simply Wall St. +12.52%
08:30AM  Zosano Reaches Enrollment Milestone in M207-ADAM Long-term Safety Study GlobeNewswire
Mar-12-18 08:45AM  Zosano Pharma Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Operational Update GlobeNewswire -10.78%
Mar-09-18 09:07AM  The Market In 5 Minutes: Trump And Kim Jung Un, Toys 'R' Us Liquidation, Zosano's Move, Big Payrolls Beat Benzinga -6.71%
Mar-08-18 07:30AM  Report: Developing Opportunities within Owens & Minor, Zosano Pharma, Organovo, Summit Materials, Ralph Lauren, and Clearside Biomedical Future Expectations, Projections Moving into 2018 GlobeNewswire +27.25%
Mar-05-18 08:10AM  Todays Research Reports on Stocks to Watch: Nektar Therapeutics and Zosano Pharma ACCESSWIRE
Mar-02-18 08:30AM  Zosano Pharma Announces Issuance of New U.S. Patent Covering M207 as an Acute Treatment for Migraine GlobeNewswire +39.38%
Feb-27-18 08:30AM  Todays Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Zosano Pharma ACCESSWIRE +7.94%
Jan-25-18 09:00AM  Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split GlobeNewswire -13.02%
Jan-03-18 08:30AM  Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine GlobeNewswire +7.55%
Jan-02-18 01:29PM  Want To Invest In Zosano Pharma Corporation (NASDAQ:ZSAN)? Heres How It Performed Lately Simply Wall St.
Dec-26-17 04:04PM  Iconix, PPL Corp. Slip into Tuesdays 52-Week Low Club 24/7 Wall St. -9.28%
Dec-15-17 04:30PM  Zosano Announces Resignation of Bruce Steel from Board of Directors GlobeNewswire +6.12%
Nov-21-17 12:39PM  Is Zosano Pharma Corporation (ZSAN) A Financially Sound Company? Simply Wall St. -8.82%
Nov-15-17 09:00AM  Zosano Pharma to Present at 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire +7.69%
Nov-09-17 04:05PM  Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update GlobeNewswire
Nov-08-17 08:30AM  Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine GlobeNewswire
Nov-01-17 08:30AM  Zosano Pharma to Host Conference Call on Third Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire +12.54%
Oct-20-17 04:15PM  Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital GlobeNewswire
Oct-12-17 02:43PM  Zosano Announces Publication of Pivotal Data of ADAM Zolmitriptan for the Acute Treatment of Migraine in Cephalalgia GlobeNewswire +5.61%
Oct-11-17 08:00AM  Today's Research Reports on Trending Tickers: Insys Therapeutics and Zosano Pharma Corporation ACCESSWIRE +11.46%
Oct-04-17 09:00AM  Zosano Appoints Kenneth Greathouse to Board of Directors GlobeNewswire
Sep-26-17 05:03PM  Zosano Provides Patent Application Update GlobeNewswire -5.93%
Sep-13-17 11:36AM  Zosano Presents Data from ZOTRIP Study at International Headache Society GlobeNewswire +10.31%
Aug-28-17 08:30AM  Zosano Pharma Announces US Patent Office Publication of Method of Rapidly Achieving Therapeutic Concentrations of Triptans for Treatment of Migraines GlobeNewswire
Aug-10-17 04:01PM  Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update GlobeNewswire -5.05%
03:30PM  Investor Network: Zosano Pharma Corp. to Host Earnings Call ACCESSWIRE
Aug-02-17 08:30AM  Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire
Jul-31-17 09:30AM  Zosano Announces Publication of Positive Phase 1 Data of Zolmitriptan Delivery In Future Medicines Pain Management Journal GlobeNewswire
Jun-26-17 08:30AM  Zosano Pharma Announces Outcome of End of Phase 2 Meetings with FDA GlobeNewswire
Jun-14-17 04:01PM  Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jun-12-17 08:30AM  Zosano Presents Additional Data from ZOTRIP Study at American Headache Society, Demonstrating Positive Results for Pain Freedom and Sustained Pain Freedom GlobeNewswire -9.33%
Jun-01-17 08:30AM  Zosano to Present Migraine Data at Three Industry-Leading Conferences GlobeNewswire
May-30-17 08:00AM  Today's Research Reports on Stocks to Watch: BioDelivery Sciences International and Zosano Pharma Accesswire
May-26-17 11:15PM  Zosano Pharma Corp (ZSAN) Interim CEO John Peter Walker Bought $100,254 of Shares GuruFocus.com +12.03%
May-09-17 04:00PM  Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes GlobeNewswire
03:05PM  Investor Network: Zosano Pharma Corp. to Host Earnings Call Accesswire
May-08-17 05:30AM  Zosano Pharma to Host Conference Call on First Quarter 2017 Financial Results and Provide Operational Update GlobeNewswire
Apr-17-17 09:20AM  5 Drug Stocks That Could Be Big Winners this Earnings Season Zacks
Apr-04-17 09:47AM  Shkreli Gives Zosano a Giant Headache Investopedia -10.38%
09:47AM  Shkreli Gives Zosano a Giant Headache
Mar-31-17 12:00PM  Penny Stocks to Watch for April 2017 (ATRS, WRN) at Investopedia
Mar-22-17 04:01PM  Zosano Announces Closing of Public Offering of Common Stock and Exercise of Underwriters Over-Allotment Option GlobeNewswire
Mar-17-17 09:25AM  Zosano Announces Pricing of Public Offering of Common Stock GlobeNewswire -9.88%
08:55AM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Mar-07-17 01:04PM  ZOSANO PHARMA CORP Financials -5.53%
Mar-02-17 05:21PM  Penny Stocks to Watch for March 2017 (MOBL) Investopedia
05:21PM  Penny Stocks to Watch for March 2017 (MOBL)
Mar-01-17 07:31AM  ZOSANO PHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
07:00AM  Zosano Pharma Reports Fourth Quarter and Fiscal 2016 Financial Results and Business Update GlobeNewswire
06:16AM  ZOSANO PHARMA CORP Files SEC form 10-K, Annual Report
Feb-16-17 09:30AM  Biotech Industry Shaping up to Have a Breakout Year in 2017: Today's Reports on Insys Therapeutics and Zosano Pharma Accesswire +7.72%
Feb-14-17 10:47AM  Zosano Pharma Corp (ZSAN) Is Playing With The Big Boys In The Migraine Space Insider Monkey +18.82%
10:47AM  Zosano Pharma Corp (ZSAN) Is Playing With The Big Boys In The Migraine Space at Insider Monkey
Feb-13-17 04:20PM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +41.67%
11:10AM  Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win? 24/7 Wall St.
11:10AM  Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?
10:36AM  Fear of Missing Out Is Building TheStreet.com
10:36AM  Fear of Missing Out Is Building
09:56AM  Zosana Pharma's stock rockets after migraine patch produces positive trial results at MarketWatch
08:30AM  Zosano Pharma Announces 3.8mg Dose of M207, its Novel Transdermal Therapeutic, Meets Both Co-primary Endpoints in the ZOTRIP Pivotal Efficacy Trial in Migraine GlobeNewswire
Jan-25-17 04:37PM  ZOSANO PHARMA CORP Files SEC form 8-K, Other Events
Jan-23-17 05:18PM  Zosano Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-05-17 08:30AM  Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial GlobeNewswire +11.47%
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Amzak Capital Management, LLC10% OwnerFeb 27Sale8.265,90148,7600Feb 28 05:38 PM
Amzak Capital Management, LLC10% OwnerFeb 27Sale8.3680,880675,914175,211Feb 28 05:38 PM
Amzak Capital Management, LLC10% OwnerFeb 26Sale11.001,50016,500256,091Feb 28 05:38 PM